leisure time -WSS

leisure time

author：focus 2025-09-29 12:09:32 - browse：8869

Diversity in clinical trials concept — Adobe

The persistent lack of diversity among participants in clinical trials is a critical issue that is harming both populations that have long been left out of pivotal medical studies and the entire biomedical research enterprise, according to the authors of a report released Tuesday by the National Academies of Sciences, Engineering and Medicine.

Describing the need to move away from trials that focus largely on white men as “urgent,” the report’s authors called for a paradigm shift that gives less power to institutions that fund and conduct clinical research and more to communities under study. The sternly worded report said funding to include and recruit more diverse participants should be a priority that is enforced and said such investments could eventually lead to massive cost savings as the nation’s health disparities are reduced.

“An equitable clinical research enterprise would include trials and studies that match the demographics of the disease burden under study,” the report said. “However, we remain far from achieving this goal.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Making the case for fair compensation in clinical trials

WSS

The United States is paying nearly triple for new Covid vaccines

The United States is paying nearly triple for new Covid vaccines

Lawsuit highlights wrinkle for disputes over surprise medical bills

Addressing health care workers' trauma can help fight burnout

Study points to new risk in gene therapy death of Terry Horgan

Liver decline slowed by off

focus

leisure time

knowledge

Peter Hotez and the public health issue of online harassment

The stability of $0 premiums in Medicare Advantage

New air purifier tech could be key to improving indoor air quality

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Anesthesiologist group: stop taking Ozempic before surgery

The Karikó problem: Lessons for funding basic research

Affirmative action in medical school literally saved lives

ASCO eve: Let’s set the table for this year's meeting

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

ASCO eve: Let’s set the table for this year's meeting

entertainment

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Investigation reveals sickle cell patients pressured into sterilizations

As a primary care physician, here's how I hope to partner with AI

Addressing health care workers' trauma can help fight burnout

With Roe v Wade overturned, abortion providers work to adapt

WHO recommends second malaria vaccine

knowledge

explore

explore

focus